文献速递血液淋巴病理细胞病理与分子病理

光学基因组图谱在儿童血液肿瘤中的诊断价值

Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia Subtypes.
PubMed 文献 · Mod Pathol · 2025-11-14

研究回顾100例儿童血液肿瘤,比较OGM与SOC检测。OGM作为单一检测可识别92%的临床显著变异,并在22%病例中发现SOC遗漏的1/2级变异,T-ALL获益最大。

要点

  • OGM可检测常规FISH和OncoKids未覆盖的隐匿性平衡重排。
  • T-ALL中近40%(9/23)病例经OGM发现额外1/2级变异。
  • OGM对拷贝中性杂合性缺失分辨率低,7例遗漏临床显著变异。

核心结论

  • OGM是检测儿童血液肿瘤拷贝数异常和平衡结构变异的有力方法。

研究设计与样本

  • 回顾性比较100例初诊或复发儿童血液肿瘤的SOC检测与OGM结果。

主要发现

  • OGM与SOC检测完全一致率为71%。
  • OGM遗漏7例临床显著变异,但在22例中发现SOC遗漏的1/2级变异。
  • T-ALL中近40%(9/23)病例经OGM发现额外1/2级变异。
  • OGM作为单一检测识别了SOC联合检测发现的92%临床显著变异。

关键数值与推荐

  • 临床显著变异依据AMP/ASCO/CAP指南分为1级或2级。
  • SOC检测包括核型分析、FISH、染色体微阵列和OncoKids panel。

临床怎么用

  • OGM可作为儿童血液肿瘤全面基因组检测的候选方法,尤其适用于T-ALL。
  • 需注意OGM对拷贝中性杂合性缺失分辨率低,可能遗漏相关变异。

局限性

  • OGM对拷贝中性杂合性缺失分辨率低。
  • 回顾性设计,样本量100例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hematologic neoplasms in pediatric patients have different genomic profiles compared with the same malignancies in adults, with copy number abnormalities (CNAs) and balanced structural variants (SVs) being the most prevalent types of oncogenic drivers. Consequently, we hypothesized that optical genome mapping (OGM), as a new method for genome-wide, high-resolution detection of CNAs and balanced SVs, could represent a powerful testing approach for pediatric leukemias. This study compared the performance of OGM in the detection of clinically significant variants with current standard-of-care (SOC) diagnostic methodologies, including karyotyping, fluorescence in situ hybridization (FISH), chromosomal microarray, and a custom pediatric next-generation sequencing panel, OncoKids. In a retrospective review of results from SOC genetic testing and OGM for 100 de novo or relapsed pediatric hematologic neoplasms, full concordance was observed in 71% of cases. A clinically significant finding (tier 1 or 2 based on the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists guidelines) was missed by OGM in 7 cases, but in 22 cases, OGM identified additional tier 1 or 2 findings missed by SOC testing. The highest increase in diagnostic yield was noted in T-lymphoblastic leukemia/lymphoma (T-ALL), with nearly 40% (9/23) of T-ALL cases having additional tier 1 or 2 findings detected using OGM. The main advantage of OGM was the ability to detect cytogenetically cryptic, balanced rearrangements not targeted by routine FISH probes or OncoKids, whereas its main limitation was low resolution for identifying copy-neutral loss of heterozygosity. As a single assay, OGM detected the majority (92%) of clinically significant variants identified by the combined use of karyotyping, FISH, chromosomal microarray, and OncoKids, and revealed additional tier 1 or 2 variants missed by SOC testing in 22% of the cases. Our study shows that OGM represents a powerful assay for detection of CNAs and balanced SVs in pediatric hematologic neoplasms.

来源:Mod Pathol,查看原文。版权归原作者所有。

引用

  1. Smith TH, Jean J, Phan S, et al. Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia Subtypes. Mod Pathol. 2025. PMID: 41242614. doi:10.1016/j.modpat.2025.100937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。